reviewThe Lancet OncologyJul 6, 2014GREEN OA

Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials

RKRobert K. HillsSCSylvie CastaignéFRFrederick R. AppelbaumJDJacques DelaunaySHStephen H. Petersdorf

Cardiff University · Centre Hospitalier de Versailles · +11 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

689
total citations
FWCI
27.42
Percentile
100%
References
30
Citations per year

Authors

15

Topics & keywords

Topics
Keywords
  • Gemtuzumab ozogamicin
  • Medicine
  • Induction chemotherapy
  • Internal medicine
  • Clinical endpoint
  • Oncology
  • Chemotherapy
  • Randomized controlled trial
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.